Do you have relapsed or refractory multiple myeloma? Have you received at least one type of treatment? If so, you may be able to take part in a research study looking at the the safety of giving an investigational medication to patients with multiple myeloma.

Do you have T2DM? Are you concerned about your heart health? If you are also overweight or obese, you may be able to take part in a study where we are comparing insulin to a new oral medication to help better control diabetes, heart health, and weight loss. All current diabetes medications and study product will be paid for by the study. Compensation and diabetes care and counseling provided.

Have you been diagnosed with an advanced cancer that has not responded to or has stopped responding to treatment? Have you had genetic testing done on your cancer? If so you may be able to take park in a research study to observe how certain cancer drugs target tumor DNA. Travel reimbursement provided.

People with Barrett's esophagus are at higher than average risk of developing esophageal cancer. Obeticholic Acid (OCA) is a medication similar to bile acids (a fluid made and released by the liver). OCA binds to a group of cells in the intestine that is believed to have a positive effect on preventing cancer development. The purpose of this study is to compare the safety and effects of OCA with that of a placebo on the risk of developing esophageal cancer in people with Barrett's esophagus.

Have you been newly diagnosed with or suspected of having either acute myelogenous leukemia or high risk myeloid neoplasm? Are you looking for other treatment options? In this study, depending on the specific type of leukemia you have, our study team will determine the different treatment options that we can provide to you.

Do you have essential thrombocythemia (ET)? If you need to start therapy or your currently therapy is not controlling your ET, you may be able to take part in this research study to find out if a new drug can help normalize your blood count.

The purpose of this study is to find out how the study drug, Avelumab, works on Merkel Cell cancer that has traveled to lymph nodes in patients who have had surgery and radiation.

Do you want to help in the design of a new device that can electronically measure and track your strength? We are testing a new system that uses an electronic resistance exercise band and an 'app' designed for older adults to improve strength and prevent weakness. If you have an interest, you may be able to share your opinions on the device with us! We will provide $50 in gas card incentives.

Do you ever feel like your doctor doesn't hear or understand what your needs are? Does it feel like your doctor is always rushing you and there's never enough time to address what's really important in your health. You may be eligible to participate in a focus group study to find out more about what health issues doctors are missing during health appointments and how communication between patient and doctor can be improved.

Have you taken a GLP-1 agonist drug such as semaglutide for weight loss? You may be able to participate in a research study to find out if taking GLP-1 agonist drugs such as semaglutide have any effect on physical function or quality of life.